Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 3 RANDOMIZED TRIAL OF NEOADJUVANT CHEMOTHERAPY, EXCISION AND OBSERVATION VERSUS CHEMORADIOTHERAPY FOR EARLY RECTAL CANCER

Intervention/treatment:
CAPECITABINE/ FLUOROURACIL/ LEUCOVORIN/ OXALIPLATIN
Medical condition:
RECTAL CANCER
Protocol code:
CO.32
Control number:
283641
Status:
Recruiting
Approved:
March 01, 2024
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT06205485
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Chris O'Callaghan
Role
CONTACT
Phone:
613-533-6430
Sponsor
CANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITY

Locations

British Columbia

BCCA-Vancouver Cancer Centre
Vancouver, British Columbia, V5Z 4E6
RECRUITING
Name
Site Public Contact
Role
CONTACT
Phone:
888-939-3333
Name
Jonathan M. Loree
Role
PRINCIPAL_INVESTIGATOR

Manitoba

CancerCare Manitoba
Winnipeg, Manitoba, R3E 0V9
RECRUITING
Name
Site Public Contact
Role
CONTACT
Phone:
866-561-1026
Name
Eric Hyun
Role
PRINCIPAL_INVESTIGATOR

Newfoundland and Labrador

Doctor H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, A1B 3V6
RECRUITING
Name
Site Public Contact
Role
CONTACT
Phone:
709-777-7589
Extension 3329
Name
Teri L. Stuckless
Role
PRINCIPAL_INVESTIGATOR

Ontario

London Regional Cancer Program
London, Ontario, N6A 4L6
RECRUITING
Name
Site Public Contact
Role
CONTACT
Phone:
519-685-8600
Extension 3329
Name
Terry M. Zwiep
Role
PRINCIPAL_INVESTIGATOR
Ottawa Hospital and Cancer Center-General Campus
Ottawa, Ontario, K1H 8L6
RECRUITING
Name
Site Public Contact
Role
CONTACT
Phone:
613-761-4395
Name
Kristopher Dennis
Role
PRINCIPAL_INVESTIGATOR

Quebec

CIUSSSEMTL-Hopital Maisonneuve-Rosemont
Montreal, Quebec, H1T 2M4
RECRUITING
Name
Site Public Contact
Role
CONTACT
Phone:
514-252-3400
Extension 3329
Name
Mikael Soucisse
Role
PRINCIPAL_INVESTIGATOR

Saskatchewan

Allan Blair Cancer Centre
Regina, Saskatchewan, S4T 7T1
RECRUITING
Name
Site Public Contact
Role
CONTACT
Phone:
306-766-2213
Name
Mussawar Iqbal
Role
PRINCIPAL_INVESTIGATOR
Saskatoon Cancer Centre
Saskatoon, Saskatchewan, S7N 4H4
RECRUITING
Name
Site Public Contact
Role
CONTACT
Phone:
306-655-2914
Name
Shahid Ahmed
Role
PRINCIPAL_INVESTIGATOR
Did you find what you were looking for?

Contacts and resources